Porfiria aguda intermitente subclínica. Etiología inusual de hepatitis crónica

[1]  L. Wetterberg,et al.  Hepatocellular carcinoma in patients with acute intermittent porphyria. , 2009, Acta medica Scandinavica.

[2]  K. Boberg,et al.  AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Simplified Criteria for the Diagnosis of Autoimmune Hepatitis , 2008 .

[3]  J. Faivre,et al.  Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors. , 2000, Journal of hepatology.

[4]  M. Manns,et al.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. , 1999, Journal of hepatology.

[5]  H. Adami,et al.  Primary liver cancer, other malignancies, and mortality risks following porphyria: a cohort study in Denmark and Sweden. , 1999, American journal of epidemiology.

[6]  J. Deybach,et al.  Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France , 1997, Journal of internal medicine.

[7]  J. Deybach,et al.  Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria. , 1997, American journal of human genetics.

[8]  F. Lithner,et al.  The epidemiology of hepatocellular carcinoma in patients with acute intermittent porphyria , 1996, Journal of internal medicine.

[9]  G. Dusheiko,et al.  Management of hepatocellular carcinoma. , 1992, Journal of hepatology.

[10]  U. Meyer,et al.  Primary liver carcinoma in two sisters with acute intermittent porphyria. , 1990, The American journal of medicine.

[11]  E. Etzioni,et al.  [Autoantibodies in liver disease]. , 1979, Harefuah.

[12]  D. Tschudy,et al.  ACUTE INTERMITTENT PORPHYRIA: A Clinical and Biochemical Study of 46 Patients , 1970, Medicine.